CVC and GBL secure 91.9% of Recordati, paving way for delisting
Tuesday, November 10, 2026 · first reported by Private Equity Wire
CVC Capital Partners and Groupe Bruxelles Lambert (GBL) now hold 91.9% of Italian pharmaceutical company Recordati after their takeover offer closed, putting them above the 90% level needed to delist the company from the Milan stock exchange. Additional shares were tendered on Monday, 9 November, and the tender period ended at 16:30 GMT. The offer was priced at €53 per share and values the business at €11bn. Private Equity Wire, citing Reuters, says the 91.9% figure uses Borsa Italiana data and leaves out any shares CVC or GBL bought on the market on the final day.
- Also named
- Recordati
- Asset class
- Private equity
- Geography
- Europe
The summary and fields above are extracted from the published reports and can contain errors. The linked articles are the source of record.
See an error?
Coverage
1 sourceMore on CVC Capital Partners
Everything on this firm →- Macquarie and GIC explore $2bn sale of Philippine geothermal stakePrivate Equity Wire
- Private credit lenders in talks to provide $1.3bn for L Catterton's Fullscript buyoutPrivate Equity Wire
- HealthSpan's Surgery Partners Bid Now $6B Amid Rival OfferLaw360
- APSEZ to buy Europe’s second-largest independent liquid storage operator from Igneo for €2.56bIREI
- Brookfield in talks to acquire China Life's 40% stake in London office towerPrivate Equity Wire
- PSP bets C$1.6bn on Enercare as it pushes Canadian assets toward C$100bnAlternatives Watch
Got news? Send it to us →